Chemoinformaics analysis of 2-[p-chlorobenzyl]Piperidine
| Molecular Weight | 209.72 | nRot | 2 |
| Heavy Atom Molecular Weight | 193.592 | nRig | 12 |
| Exact Molecular Weight | 209.097 | nRing | 2 |
| Solubility: LogS | -2.377 | nHRing | 1 |
| Solubility: LogP | 3.336 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 33.9887 |
| nHD | 1 | BPOL | 17.1313 |
| QED | 0.79 |
| Synth | 2.355 |
| Natural Product Likeliness | -0.004 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.043 |
| Pgp-sub | 0.277 |
| HIA | 0.004 |
| CACO-2 | -4.456 |
| MDCK | 0.0000115 |
| BBB | 0.991 |
| PPB | 0.727872 |
| VDSS | 2.491 |
| FU | 0.338682 |
| CYP1A2-inh | 0.661 |
| CYP1A2-sub | 0.927 |
| CYP2c19-inh | 0.595 |
| CYP2c19-sub | 0.837 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.081 |
| CYP2d6-inh | 0.985 |
| CYP2d6-sub | 0.907 |
| CYP3a4-inh | 0.061 |
| CYP3a4-sub | 0.629 |
| CL | 7.836 |
| T12 | 0.18 |
| hERG | 0.861 |
| Ames | 0.035 |
| ROA | 0.932 |
| SkinSen | 0.801 |
| Carcinogencity | 0.11 |
| EI | 0.054 |
| Respiratory | 0.938 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.628905 |